Financial Enhancement Group LLC Zimmer Biomet Holdings, Inc. Transaction History

Financial Enhancement Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$87.02 - $133.4 $8,527 - $13,073	-98 Reduced 50.78%	95 $11,000
Q1 2020 May 04, 2020	SELL	$78.28 - $155.73 $156 - $311	-2 Reduced 1.03%	193 $20,000
Q3 2019 Nov 08, 2019	SELL	$113.33 - $138.46 $2,606 - $3,184	-23 Reduced 10.55%	195 $27,000
Q2 2018 Aug 08, 2018	SELL	$102.12 - $114.04 $1,531 - $1,710	-15 Reduced 6.44%	218 $24,000
Q1 2018 Apr 30, 2018	BUY	$104.31 - $124.46 $24,304 - $28,999	233 New	233 $25,000

1,081

175M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $21.2B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Enhancement Group LLC with notifications on news.